11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases

Glucocorticoids (GCs) belong to the group of steroid hormones. Their representative in humans is cortisol. GCs are involved in most physiological processes of the body and play a significant role in important biological processes, including reproduction, growth, immune responses, metabolism, mainten...

Full description

Bibliographic Details
Main Authors: Daria Kupczyk, Renata Studzińska, Renata Kołodziejska, Szymon Baumgart, Martyna Modrzejewska, Alina Woźniak
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/20/6190
_version_ 1797407025951408128
author Daria Kupczyk
Renata Studzińska
Renata Kołodziejska
Szymon Baumgart
Martyna Modrzejewska
Alina Woźniak
author_facet Daria Kupczyk
Renata Studzińska
Renata Kołodziejska
Szymon Baumgart
Martyna Modrzejewska
Alina Woźniak
author_sort Daria Kupczyk
collection DOAJ
description Glucocorticoids (GCs) belong to the group of steroid hormones. Their representative in humans is cortisol. GCs are involved in most physiological processes of the body and play a significant role in important biological processes, including reproduction, growth, immune responses, metabolism, maintenance of water and electrolyte balance, functioning of the central nervous system and the cardiovascular system. The availability of cortisol to the glucocorticoid receptor is locally controlled by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Evidence of changes in intracellular GC metabolism in the pathogenesis of obesity, metabolic syndrome (MetS) and cardiovascular complications highlights the role of selective 11β-HSD1 inhibition in the pharmacotherapy of these diseases. This paper discusses the role of 11β-HSD1 in MetS and its cardiovascular complications and the importance of selective inhibition of 11β-HSD1.
first_indexed 2024-03-09T03:35:20Z
format Article
id doaj.art-3a030a9af9804993abf820107b0a6d39
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T03:35:20Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-3a030a9af9804993abf820107b0a6d392023-12-03T14:49:00ZengMDPI AGJournal of Clinical Medicine2077-03832022-10-011120619010.3390/jcm1120619011β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular DiseasesDaria Kupczyk0Renata Studzińska1Renata Kołodziejska2Szymon Baumgart3Martyna Modrzejewska4Alina Woźniak5Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85-092 Bydgoszcz, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasza 2, 85-089 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85-092 Bydgoszcz, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasza 2, 85-089 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85-092 Bydgoszcz, PolandDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Karłowicza 24, 85-092 Bydgoszcz, PolandGlucocorticoids (GCs) belong to the group of steroid hormones. Their representative in humans is cortisol. GCs are involved in most physiological processes of the body and play a significant role in important biological processes, including reproduction, growth, immune responses, metabolism, maintenance of water and electrolyte balance, functioning of the central nervous system and the cardiovascular system. The availability of cortisol to the glucocorticoid receptor is locally controlled by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Evidence of changes in intracellular GC metabolism in the pathogenesis of obesity, metabolic syndrome (MetS) and cardiovascular complications highlights the role of selective 11β-HSD1 inhibition in the pharmacotherapy of these diseases. This paper discusses the role of 11β-HSD1 in MetS and its cardiovascular complications and the importance of selective inhibition of 11β-HSD1.https://www.mdpi.com/2077-0383/11/20/619011β-hydroxysteroid dehydrogenaseglucocorticoidsmetabolic syndromecardiovascular diseases11β-HSD1 selective inhibitors
spellingShingle Daria Kupczyk
Renata Studzińska
Renata Kołodziejska
Szymon Baumgart
Martyna Modrzejewska
Alina Woźniak
11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases
Journal of Clinical Medicine
11β-hydroxysteroid dehydrogenase
glucocorticoids
metabolic syndrome
cardiovascular diseases
11β-HSD1 selective inhibitors
title 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases
title_full 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases
title_fullStr 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases
title_full_unstemmed 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases
title_short 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases
title_sort 11β hydroxysteroid dehydrogenase type 1 as a potential treatment target in cardiovascular diseases
topic 11β-hydroxysteroid dehydrogenase
glucocorticoids
metabolic syndrome
cardiovascular diseases
11β-HSD1 selective inhibitors
url https://www.mdpi.com/2077-0383/11/20/6190
work_keys_str_mv AT dariakupczyk 11bhydroxysteroiddehydrogenasetype1asapotentialtreatmenttargetincardiovasculardiseases
AT renatastudzinska 11bhydroxysteroiddehydrogenasetype1asapotentialtreatmenttargetincardiovasculardiseases
AT renatakołodziejska 11bhydroxysteroiddehydrogenasetype1asapotentialtreatmenttargetincardiovasculardiseases
AT szymonbaumgart 11bhydroxysteroiddehydrogenasetype1asapotentialtreatmenttargetincardiovasculardiseases
AT martynamodrzejewska 11bhydroxysteroiddehydrogenasetype1asapotentialtreatmenttargetincardiovasculardiseases
AT alinawozniak 11bhydroxysteroiddehydrogenasetype1asapotentialtreatmenttargetincardiovasculardiseases